Valneva SE Sponsored ADR

VALN Healthcare Biotechnology

Valneva SE Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $197.6 million, up 7.69% from fiscal 2024.

Revenue
−17.3%
EPS
−222.1%
Free cash flow
−56.1%
Total debt
+12.1%

Quarter to June 2026, against a year earlier

5.57 0.07 −1.24%
Market cap
$536.5M
P/E
59.3×
Fwd P/E
19.4×
Dividend yield
—
F-score
2/9
Altman Z
−0.49
Beneish M
−3.28
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Piotroski F-Score
2 4 2 0 5 4 — — — —
P/E ratio
22.99 18.71 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
(0.49) (0.12) (0.15) 0.61 2.22 — — — — —
P/S ratio
3.95 1.97 2.98 2.55 18.65 10.28 10.28 10.28 10.28 10.28
P/FCF ratio
0.00 0.00 0.00 0.00 13.73 4.16 4.16 4.16 4.16 4.16
Altman Z″-Score (non-manufacturers)
(3.49) (0.40) (2.50) (0.71) 0.58 0.10 0.74 1.66 — (0.34)
Beneish M-Score
(3.28) (2.16) 0.03 (0.39) (1.49) (4.89) (1.73) — — —
P/Operating CF
(20.45) (3.63) (4.77) (15.20) (46.23) 21.26 21.26 21.26 21.26 21.26
P/B ratio
3.86 1.28 4.14 4.03 29.76 19.32 19.32 19.32 19.32 19.32
EV/Sales
4.12 2.08 2.84 2.16 16.87 8.44 8.44 8.44 8.44 8.44
EV/EBITDA
30.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/FCF
(4.45) (0.96) (2.12) (2.43) 12.42 3.41 3.41 3.41 3.41 3.41
Current Ratio
2.38 2.61 1.65 1.53 1.59 1.75 3.13 2.93 2.22 2.34
Net Debt/EBITDA
(1.15) 0.58 (0.79) 2.06 6.13 3.33 16.81 (2.69) 5.31 12.75
Debt/Equity
1.69 1.03 1.38 0.45 0.34 0.69 0.63 0.40 0.77 0.82
ROE
(82.42%) (7.91%) (59.28%) (69.66%) (59.86%) (61.22%) (1.24%) 2.72% (12.75%) (47.72%)
ROA
(26.27%) (2.55%) (19.05%) (18.62%) (11.74%) (17.92%) (0.67%) 1.52% (12.70%) (23.22%)
ROIC
(29.19%) 4.16% (28.66%) (243.03%) 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(46.32%) (3.79%) (42.23%) (55.17%) (21.44%) (38.48%) (1.11%) 2.70% (13.65%) (53.84%)
Average Days of Receivables
58.12 75.77 98.89 24.16 46.15 63.63 69.50 36.36 61.09 65.63
Earnings Yield
4.35% 5.35% (9.93%) (12.27%) (10.78%) (5.75%) (5.75%) (5.75%) (5.75%) (5.75%)
Free Cash Flow Yield
(23.41%) (109.75%) (45.07%) (34.73%) 7.28% 24.06% 24.06% 24.06% 24.06% 24.06%
Free Cash Flow per Share
(0.77) (1.24) (3.39) (5.01) (0.39) 2.98 0.08 0.35 0.17 (0.03)
Book value per Share
1.43 2.69 2.00 4.01 4.13 1.95 3.31 4.09 2.03 2.59
Free Cash Flow
(64.77) (90.35) (234.80) (289.38) (19.25) 135.12 3.49 14.16 9.54 (1.20)
EV/EBIT
24.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026